Neo Cremar Co., Ltd. (KOSDAQ:311390)
4,560.00
-95.00 (-2.04%)
At close: Apr 23, 2026
Neo Cremar Revenue
In the year 2025, Neo Cremar had annual revenue of 81.94B KRW with 103.27% growth. Neo Cremar had revenue of 21.65B in the quarter ending December 31, 2025, a decrease of -4.75%.
Revenue
81.94B
Revenue Growth
+103.27%
P/S Ratio
0.72
Revenue / Employee
1.26B
Employees
65
Market Cap
58.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.94B | 41.63B | 103.27% |
| Dec 31, 2024 | 40.31B | 15.45B | 62.12% |
| Dec 31, 2023 | 24.87B | -1.84B | -6.88% |
| Dec 31, 2022 | 26.70B | -3.18B | -10.65% |
| Dec 31, 2021 | 29.89B | 65.63M | 0.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samkee | 570.54B |
| CoAsia CM Co.,Ltd | 258.20B |
| Daewon | 112.12B |
| WooDeumGee Farm | 63.68B |
| Kyung Nam Pharm | 56.18B |
| Elcomtec | 46.29B |
| TBC | 42.69B |
| Cellromax Science | 22.18B |